CTI BioPharma Net Worth 2006-2019 | CTIC

Interactive chart of historical net worth (market cap) for CTI BioPharma (CTIC) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. CTI BioPharma net worth as of October 22, 2019 is $0.05B.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.046B $0.026B
CTI BioPharma Corp. is a biopharmaceutical company. It is focused on the acquisition, development and commercialization of therapies covering a spectrum of blood-related cancers. The company is heavily focused on marketing its approved therapy Pixuvri in Europe, and on continuing the development of its late-stage development pipeline, including pacritinib. CTI BioPharma Corp., formerly known as Cell Therapeutics, Inc., is headquartered in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $58.649B 36.12
Takeda Pharmaceutical (TAK) Japan $54.706B 8.56
Astellas Pharma (ALPMY) Japan $31.284B 14.91
Eisai (ESALY) Japan $19.483B 29.83
Merck (MKGAF) Germany $15.238B 20.79
UCB SA (UCBJF) Belgium $14.373B 0.00
Grifols, S.A (GRFS) Spain $14.294B 18.24
Ono Pharmaceutical (OPHLF) Japan $9.212B 19.69
Neurocrine Biosciences (NBIX) United States $8.986B 0.00
IPSEN SA ADR (IPSEY) France $8.872B 0.00
Ionis Pharmaceuticals (IONS) United States $7.690B 16.58
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 0.00
Sage Therapeutics (SAGE) United States $7.216B 0.00
Catalent (CTLT) United States $7.080B 27.98
Jazz Pharmaceuticals (JAZZ) Ireland $6.939B 9.13
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.094B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Hypermarcas (HYPMY) Brazil $5.292B 19.02
Orion OYJ (ORINY) Finland $5.271B 27.14
Arrowhead Pharmaceuticals (ARWR) United States $3.695B 84.73
United Therapeutics (UTHR) United States $3.695B 0.00
FibroGen (FGEN) United States $3.443B 86.11
Evotec AG (EVTCY) Germany $3.224B 44.14
Nektar Therapeutics (NKTR) United States $3.015B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.993B 10.73
PTC Therapeutics (PTCT) United States $2.304B 0.00
Tilray (TLRY) Canada $2.163B 0.00
Xencor (XNCR) United States $2.060B 44.93
Portola Pharmaceuticals (PTLA) United States $1.936B 0.00
Zogenix (ZGNX) United States $1.924B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.644B 59.82
USANA Health Sciences (USNA) United States $1.616B 16.77
Corcept Therapeutics (CORT) United States $1.591B 21.86
Heron Therapeutics (HRTX) United States $1.483B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.410B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.308B 0.00
Radius Health (RDUS) United States $1.251B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.195B 19.72
ArQule (ARQL) United States $1.148B 0.00
Endo (ENDP) Ireland $1.064B 1.87
Aerie Pharmaceuticals (AERI) United States $0.965B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.945B 0.00
TherapeuticsMD (TXMD) United States $0.907B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.900B 4.01
Spectrum Pharmaceuticals (SPPI) United States $0.893B 0.00
Dova Pharmaceuticals (DOVA) United States $0.810B 0.00
Organogenesis Holdings (ORGO) United States $0.716B 0.00
Karyopharm Therapeutics (KPTI) United States $0.704B 0.00
Concordia (CXRXF) Canada $0.588B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.565B 0.00
Flexion Therapeutics (FLXN) United States $0.562B 0.00
Akebia Therapeutics (AKBA) United States $0.506B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.472B 0.00
Lannett Co Inc (LCI) United States $0.472B 4.97
Aptorum Group (APM) Hong Kong, SAR China $0.464B 0.00
ChemoCentryx (CCXI) United States $0.460B 0.00
Translate Bio (TBIO) United States $0.449B 0.00
Siga Technologies (SIGA) United States $0.441B 1.03
Indivior (INVVY) United States $0.440B 1.59
ImmunoGen (IMGN) United States $0.418B 0.00
Dermira (DERM) United States $0.400B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.396B 0.00
Collegium Pharmaceutical (COLL) United States $0.382B 0.00
DURECT (DRRX) United States $0.380B 0.00
Innate Pharma SA (IPHYF) France $0.363B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.346B 15.74
Corbus Pharmaceuticals Holdings (CRBP) United States $0.334B 0.00
OptiNose (OPTN) United States $0.327B 0.00
Molecular Templates (MTEM) United States $0.327B 0.00
Harpoon Therapeutics (HARP) United States $0.318B 0.00
Ardelyx (ARDX) United States $0.315B 0.00
Rafael Holdings (RFL) United States $0.305B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.283B 0.00
Recro Pharma (REPH) United States $0.282B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.263B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.229B 0.00
GlycoMimetics (GLYC) United States $0.222B 0.00
Xeris Pharmaceuticals (XERS) United States $0.214B 0.00
CV Sciences (CVSI) United States $0.198B 0.00
KalVista Pharmaceuticals (KALV) United States $0.197B 0.00
CannTrust Holdings (CTST) Canada $0.188B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.186B 0.00
Nature's Sunshine Products (NATR) United States $0.180B 30.03
Foamix Pharmaceuticals (FOMX) Israel $0.179B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.174B 0.00
Ocular Therapeutix (OCUL) United States $0.171B 0.00
Taiwan Liposome (TLC) Taiwan $0.168B 0.00
IMV INC (IMV) Canada $0.148B 0.00
Calithera Biosciences (CALA) United States $0.146B 0.00
Concert Pharmaceuticals (CNCE) United States $0.146B 0.00
Redhill Biopharma (RDHL) Israel $0.145B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.136B 0.00
MEI Pharma (MEIP) United States $0.124B 0.00
Generex Biotechnology (GNBT) United States $0.123B 0.00
Jounce Therapeutics (JNCE) United States $0.116B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.116B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Cardiome Pharma (CORV) Canada $0.100B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.087B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.083B 31.76
Entasis Therapeutics Holdings (ETTX) United States $0.082B 0.00
Aquestive Therapeutics (AQST) United States $0.080B 0.00
MediWound (MDWD) Israel $0.077B 0.00
Majesco Entertainment (PTE) United States $0.077B 0.00
Lipocine (LPCN) United States $0.076B 0.00
Champions Oncology (CSBR) United States $0.071B 0.00
Neos Therapeutics (NEOS) United States $0.070B 0.00
Genocea Biosciences (GNCA) United States $0.068B 0.00
Otonomy (OTIC) United States $0.068B 0.00
Melinta Therapeutics (MLNT) United States $0.067B 0.00
Aclaris Therapeutics (ACRS) United States $0.067B 0.00
Natural Alternatives (NAII) United States $0.065B 9.78
AgeX Therapeutics (AGE) United States $0.064B 0.00
Infinity Pharmaceuticals (INFI) United States $0.063B 0.00
Novan (NOVN) United States $0.062B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.061B 0.00
SCYNEXIS (SCYX) United States $0.061B 0.00
ElectroCore (ECOR) United States $0.058B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.056B 0.00
IntelGenx Technologies (IGXT) Canada $0.056B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.053B 0.00
Nivalis Therapeutics (ALPN) United States $0.052B 0.00
Iterum Therapeutics (ITRM) Ireland $0.050B 0.00
Capnia (SLNO) United States $0.048B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
India Globalization Capital (IGC) United States $0.039B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.037B 0.00
Mast Therapeutics (SVRA) United States $0.036B 0.00
Bio-Path Holdings (BPTH) United States $0.035B 0.00
Opexa Therapeutics (ACER) United States $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.034B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.034B 0.00
Biomerica (BMRA) United States $0.031B 0.00
PharmAthene (ALT) United States $0.031B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
IsoRay (ISR) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.015B 0.00
Shineco (TYHT) China $0.015B 18.08
Regulus Therapeutics (RGLS) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Heat Biologics (HTBX) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
HANCOCK JAFFE (HJLI) United States $0.013B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.013B 0.00
Vical (BBI) United States $0.012B 0.00
Achieve Life Sciences (ACHV) United States $0.012B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
Onconova Therapeutics (ONTX) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Hemispherx BioPharma (AIM) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00